Blog

We are passionate about what we do

and we want to share that passion with you.

TECHNICAL FOCUS:

Fibroblast senescence model for skin longevity research

Key takeaway:

The replicative senescence fibroblast model provides a robust in vitro platform for assessing the impact of cosmetic actives on intrinsic skin aging mechanisms.

Understanding the biological mechanisms behind intrinsic skin aging is essential for developing innovative anti-aging interventions.

Our team has established a fibroblast senescence model based on the Hayflick limit, which accurately mimics age-related cellular exhaustion (Hayflick L, 1961).

Download our flyer on

Cellular Senescence

Aging Biomarkers and Cellular Alterations

With successive cell divisions, dermal fibroblasts progressively lose their proliferative capacity and enter a senescent state, exhibiting:

  • Morphological changes: Enlarged, flattened cells with altered cytoskeletal organization.
  • Senescence markers: Increased expression of proteins regulating the cell cycle, such as p16, which leads to irreversible cell cycle arrest, along with a marked decrease in Ki67, a key proliferation marker.
  • Extracellular matrix (ECM) remodeling: Decreased synthesis of collagen, hyaluronic acid, glycosaminoglycans, and elastin, along with upregulated MMPs (MMP-1, MMP-3), leading to matrix degradation.
  • Oxidative stress and SASP-driven inflammation: Senescent fibroblasts develop a SASP, which sustains chronic low-grade inflammation (inflammaging) and exacerbates oxidative stress.

Download our brochure on

Skin Longevity

Using this well-characterized model, our team enables targeted efficacy testing, supporting the development of next-generation cosmetic actives designed to promote skin longevity by preserving cellular function, extracellular matrix integrity, and resilience over time.

ECM Remodeling

Test: Procollagen I Synthesis

Method: ELISA

Observation: The addition of the test compound prevents the decline in procollagen I synthesis observed in senescent fibroblasts.

Cytoskeletal organization

Test: Actin Expression

Method: Immunofluorescence (actin: red)

Observation: Actin expression is reduced in senescent fibroblasts, which leads to defects in cytoskeletal organization. Decrease in actin expression is prevented by the addition of the test compound.

Migration capacity

Test: Fibroblast Migration

Method: Immunofluorescence

Observation: Senescent fibroblasts exhibit reduced migratory capacity, leading to a prolonged time to achieve complete closure of a cell-free area. Results shown correspond to the same time point.

Dermal Contractility

Test: Dermal Contraction

Method: Surface Area Measurement

Observation: Senescent fibroblasts exhibit reduced contractile capacity.

Procollcagen I in fibroblast senescence model
Normal"Aged"
"Aged"+Test compound
Contraction capacity of normal fibroblast and in fibroblast senescence model

Written by:

Mara Carloni, PhD

Scientific Communications & Marketing Project Leader

Interested in using this model for your Skin Aging & Longevity projects?

This field is for validation purposes and should be left unchanged.

Hello! How can we help you?

Name(Required)

By contacting QIMA Life Sciences you agree to our privacy policy and terms and conditions.